Patient Advocacy and Community Engagement at Alkermes
NORTHAMPTON, MA / ACCESSWIRE / December 11, 2023 / AlkermesOriginally published in Alkermes September 2023 Corporate Responsibility ReportWe have developed and now manufacture and commercialize proprietary medicines for the treatment of alcohol dependence, opioid dependence, schizophrenia and bipolar I disorder - di...
United States Jessicam Lipschitz Xiaoting Wu Research Development Irish Cancer Society National Council For Mental
Source: pharmiweb.com